MICHAEL CARNAHAN: Open Payments
NPI 1871607903 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 12 payments from 7 companies in 2025. Trend: 2023 $625 · 2024 $198 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Novo Nordisk Inc | 3 | $66 |
| Boston Scientific Corporation | 1 | $44 |
| Tactile Systems Technology Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, Intracept, Ozempic, QULIPTA, Rybelsus, Flexitouch Plus, FARXIGA, Kerendia.
Industry payments across OK — which companies pay providers there.
